放射肿瘤学替代支付模型基准化:16种常见放射治疗疗程的 Medicare 报销变化
该研究分析了2010年至2020年16种常见放射治疗疗程在 Medicare 按服务收费模式下的 inflation 和 utilization 调整后报销变化。结果显示所有16种疗程的平均报销均下降,其中调强放疗疗程降幅最大(38%–39%);2015年至2020年仅姑息性二维10次30 Gy疗程报销增加0.4%。作者建议政策制定者在调整报销或强制推行新支付系统时考虑已发生的显著削减及其对医疗质量和可及性的负面影响。
要点
- 2010年至2020年,16种常见放疗疗程的平均报销全部下降,调强放疗疗程降幅最大为38%–39%。
- 2015年至2020年,唯一报销增加的疗程是姑息性二维10次30 Gy,增幅0.4%。
- 作者认为政策制定者应考虑已发生的显著报销削减对医疗质量和可及性的负面影响。
核心结论
- 2010年至2020年常见放射肿瘤学疗程的报销显著下降,调强放疗疗程降幅最大。
- 作者认为政策制定者在调整现行按服务收费模式下的报销或考虑强制采用新支付系统时,应考虑已发生的显著报销削减及其对医疗质量和可及性的负面影响。
研究设计与样本
- 研究使用 Centers for Medicare & Medicaid Services Physician/Supplier Procedure Summary 数据库,获取2010年、2015年和2020年自由执业机构所有放射肿瘤学操作的报销数据。
- 以2020年美元计算每种 Healthcare Common Procedure Coding System 代码的 inflation 调整后平均每次计费报销额,乘以该代码各年计费频率后按疗程汇总,比较16种常见放疗疗程的平均报销。
- 分析的16种常见疗程涵盖头颈、乳腺、前列腺、肺及姑息性放疗。
主要发现
- 2010年至2020年,所有16种常见放疗疗程的平均报销均下降。
- 2015年至2020年,唯一平均报销增加的疗程是姑息性二维10次30 Gy,增加0.4%。
- 2010年至2020年,使用调强放疗的疗程平均报销降幅最大,范围为38%至39%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Radiation oncology (RO) has seen declines in Medicare reimbursement (MCR) in the past decade under the current fee-for-service model. Although studies have explored decline in reimbursement at a per-code level, to our knowledge there are no recent studies analyzing changes in MCR over time for common RO treatment courses. By analyzing changes in MCR for common treatment courses, our study had 3 objectives: (1) to provide practitioners and policymakers with estimates of recent reimbursement changes for common treatment courses; (2) to provide an estimate of how reimbursement will change in the future under the current fee-for-service model if current trends continue; and (3) to provide a baseline for treatment episodes in the event that the episode-based Radiation Oncology Alternative Payment Model is eventually implemented. Specifically, we quantified inflation- and utilization-adjusted changes in reimbursement for 16 common radiation therapy (RT) treatment courses from 2010 to 2020. Centers for Medicare & Medicaid Services Physician/Supplier Procedure Summary databases were used to obtain reimbursement for all RO procedures in 2010, 2015, and 2020 for free-standing facilities. Inflation-adjusted average reimbursement (AR) per billing instance was calculated for each Healthcare Common Procedure Coding System code using 2020 dollars. For each year, the billing frequency of each code was multiplied by the AR per code. Results were summed per RT course per year, and AR for RT courses were compared. Sixteen common RO courses for head and neck, breast, prostate, lung, and palliative RT were analyzed. AR decreased for all 16 courses from 2010 to 2020. From 2015 to 2020, the only course that increased in AR was palliative 2-dimensional 10-fraction 30 Gy, which increased by 0.4%. Courses using intensity modulated RT saw the largest AR decline from 2010 to 2020, ranging from 38% to 39%. We report significant declines in reimbursement from 2010 to 2020 for common RO courses, with the largest declines for intensity modulated RT. Policymakers should consider the significant cuts to reimbursement that have already occurred when considering future reimbursement adjustment under the current fee-for-service model or when considering mandatory adoption of a new payment system with further cuts and the negative effect of such cuts on quality and access to care.
引用
- Hogan JS, Karraker P, Fischer-Valuck BW, et al. Benchmarking the Radiation Oncology Alternative Payment Model: Changes in Medicare Reimbursement for 16 Common Radiation Therapy Treatment Courses. Pract Radiat Oncol. 2023. PMID: 37172757. doi:10.1016/j.prro.2023.04.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。